Pharmacological Risk Modification for Progression into Symptomatic Dementia: Complete Enumeration Study Utilizing Administrative Claims Record in Kashiwa City
Not Applicable
- Conditions
- Alzheimer diseases Levy body dementia
- Registration Number
- JPRN-UMIN000039040
- Lead Sponsor
- Tokyo Metropolitan geriatric Medical Center and Institute of Gerontology
- Brief Summary
In addition to older age and female sex, use of the following medications was significantly associated with NPADM: statins (HR: 0.82; p=0.001), antihypertensives (HR: 0.80; p<0.0001), non-steroidal bronchodilators (HR: 0.728; p=0.002), antidepressants (HR: 1.79; p<0.0001), poststroke medications (HR: 1.45; p=0.002), insulin (HR: 1.34; p=0.046) and antineoplastics (HR: 1.12; p=0.035).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 44303
Inclusion Criteria
Not provided
Exclusion Criteria
1. All residents in Kashiwa city who are equal to or younger than 76 years old at April 2012 2. All residents who had prescription of anti-dementia medication while between April and June 2012.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ew prescription of anti-dementia medication
- Secondary Outcome Measures
Name Time Method